(Q34984046)

5 August 2017

1 reference

title

Noninvasive monitoring of patients with chronic hepatitis C. (English)

1 reference

5 August 2017

0 references

1 reference

Robert J Fontana

1

1 reference

5 August 2017

Anna S F Lok

series ordinal

2

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

5 August 2017

1 reference

5 August 2017

volume

36

1 reference

5 August 2017

issue

5 Suppl 1

1 reference

5 August 2017

page(s)

S57-64

1 reference

Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36800

The role of laparoscopy in the diagnosis of cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36800

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36800

Historical features are poor predictors of liver fibrosis in Canadian patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36800

Characteristics of patients with dual infection by hepatitis B and C viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36800

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36800

The significance of baseline serum alanine aminotransferase on pretreatment disease characteristics and response to antiviral therapy in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36800

Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36800

Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36800

Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36800

Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36800

AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36800

Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36800

Natural course of progression of liver fibrosis in Japanese patients with chronic liver disease type C--a study of 527 patients at one establishment

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36800

Noninvasive diagnosis of hepatic fibrosis or cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36800

Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36800

Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36800

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36800

Quantitative testing of liver function in relation to fibrosis in patients with chronic hepatitis B and C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36800

Non-invasive diagnosis of esophageal varices in chronic liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36800

Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36800

Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36800

Serum YKL-40 is increased in patients with hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36800

Indocyanine green intrinsic hepatic clearance as a prognostic index of survival in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36800

Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36800

21 January 2018

Identifiers

DOI

10.1053/JHEP.2002.36800

1 reference

5 August 2017

1 reference